The role of retroperitoneal lymph node dissection in the management of testicular cancer
- 30 June 2004
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 22 (3), 225-233
- https://doi.org/10.1016/j.urolonc.2004.04.029
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- A Simple Model for Predicting Nodal Metastasis in Patients With Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors Undergoing Retroperitoneal Lymph Node Dissection OnlyJournal of Urology, 2004
- Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the TestisJournal of Urology, 2003
- RISK OF SYSTEMIC METASTASES IN CLINICAL STAGE I NONSEMINOMA GERM CELL TESTIS TUMOR MANAGED BY RETROPERITONEAL LYMPH NODE DISSECTIONJournal of Urology, 2000
- Surgery for a Post-Chemotherapy Residual Mass in SeminomaJournal of Urology, 1997
- Nerve Sparing Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Testicular CancerJournal of Urology, 1996
- The Management of Patients with Clinical Stage I Nonseminomatous Testicular Tumors and Persistently Elevated Serologic MarkersJournal of Urology, 1996
- Clinical stage B non-seminomatous germ cell testis cancer: The Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissectionEuropean Journal Of Cancer, 1995
- Non-Seminomatous Testicular Cancer Clinical Stage I: Prediction of Outcome by Histopathological ParametersOncology, 1989
- Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular CancerNew England Journal of Medicine, 1987
- Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical stage II nonseminomatous germinal testis tumorsCancer, 1984